297 related articles for article (PubMed ID: 25917568)
1. Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines.
Kondaveeti Y; Guttilla Reed IK; White BA
Cancer Lett; 2015 Aug; 364(1):44-58. PubMed ID: 25917568
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
3. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
4. Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition.
Halldorsson S; Rohatgi N; Magnusdottir M; Choudhary KS; Gudjonsson T; Knutsen E; Barkovskaya A; Hilmarsdottir B; Perander M; Mælandsmo GM; Gudmundsson S; Rolfsson Ó
Cancer Lett; 2017 Jun; 396():117-129. PubMed ID: 28323032
[TBL] [Abstract][Full Text] [Related]
5. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
[TBL] [Abstract][Full Text] [Related]
6. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
[TBL] [Abstract][Full Text] [Related]
7. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
8. EMT-induced metabolite signature identifies poor clinical outcome.
Bhowmik SK; Ramirez-Peña E; Arnold JM; Putluri V; Sphyris N; Michailidis G; Putluri N; Ambs S; Sreekumar A; Mani SA
Oncotarget; 2015 Dec; 6(40):42651-60. PubMed ID: 26315396
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.
West NR; Murray JI; Watson PH
Oncogene; 2014 Mar; 33(12):1485-94. PubMed ID: 23584474
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
11. Human biliverdin reductase promotes EMT through the ERK1/2 signal pathway in breast cancer.
Zhang M; Song S; Yi Z; Zhao X; Fu L; Wang L; Ma C; Mao M; Xing Y; Zhu D
Eur J Pharmacol; 2016 Oct; 788():45-53. PubMed ID: 27316791
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
13. Low doses ionizing radiation enhances the invasiveness of breast cancer cells by inducing epithelial-mesenchymal transition.
Zhang X; Li X; Zhang N; Yang Q; Moran MS
Biochem Biophys Res Commun; 2011 Aug; 412(1):188-92. PubMed ID: 21810413
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.
Mallini P; Lennard T; Kirby J; Meeson A
Cancer Treat Rev; 2014 Apr; 40(3):341-8. PubMed ID: 24090504
[TBL] [Abstract][Full Text] [Related]
15. Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer.
Funasaka T; Hogan V; Raz A
Cancer Res; 2009 Jul; 69(13):5349-56. PubMed ID: 19531650
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program.
Aguilar E; Marin de Mas I; Zodda E; Marin S; Morrish F; Selivanov V; Meca-Cortés Ó; Delowar H; Pons M; Izquierdo I; Celià-Terrassa T; de Atauri P; Centelles JJ; Hockenbery D; Thomson TM; Cascante M
Stem Cells; 2016 May; 34(5):1163-76. PubMed ID: 27146024
[TBL] [Abstract][Full Text] [Related]
17. Catabolic metabolism during cancer EMT.
Cha YH; Yook JI; Kim HS; Kim NH
Arch Pharm Res; 2015 Mar; 38(3):313-20. PubMed ID: 25634102
[TBL] [Abstract][Full Text] [Related]
18. Oxystressed tumor microenvironment potentiates epithelial to mesenchymal transition and alters cellular bioenergetics towards cancer progression.
Sridaran D; Ramamoorthi G; MahaboobKhan R; Kumpati P
Tumour Biol; 2016 Oct; 37(10):13307-13322. PubMed ID: 27460079
[TBL] [Abstract][Full Text] [Related]
19. Global and gene specific DNA methylation in breast cancer cells was not affected during epithelial-to-mesenchymal transition in vitro.
Smolkova B; Miklikova S; Kajabova VH; Babelova A; Yamani NE; Zduriencikova M; Fridrichova I; Zmetakova I; Krivulcik T; Kalinkova L; Matuskova M; Kucerova L; Dusinska M
Neoplasma; 2016; 63(6):901-910. PubMed ID: 27565328
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation.
Li L; Li W
Pharmacol Ther; 2015 Jun; 150():33-46. PubMed ID: 25595324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]